Our shareholder engagement talks give the impact community the opportunity to exchange ideas with the decision-makers in the companies. It’s an ideal opportunity to learn more about their understanding and strategy of sustainability, both in terms of products and services (handprint) and business practices (footprint), and to ask for more details if necessary.
In this report, the following is covered:
- Brief introduction to the company Zur Rose (parent company of DocMorris)
- Handprint:
- Access to medicine
- Footprint:
- CO2 footprint
- Gender equality
- Fair wages
- Main takeaways
On 30 November 2021, the CEO of Zur Rose Group, Walter Oberhänsli, was our guest. His company is best known in Germany for its online pharmacy, DocMorris, which is shaking up the pharmacy market. This was also the main focus of the brief presentation of the company.
According to Walter Oberhänsli, the pharmacy market is characterised by centuries-old traditions and is outdated. Today we can buy almost everything online: groceries, shoes, furniture etc. But when it comes to medicine, e-commerce isn’t yet widespread. People with chronic diseases are unable to comfortably secure the medical care they need via an online platform. Zur Rose wants to change that through an “ecosystem of healthcare”. Everything should be possible via an app, which would improve the lives of hundreds of thousands of chronically ill people.
In our engagement talk, we took a close look at Zur Rose. Here are the most important topics we discussed.
Handprint: Access to medicine
Zur Rose’s vision is to provide improved access to medicine for all people. On average, the medicine they offer online is about 40% cheaper than medicine found in local pharmacies. However, around 80% of the medicine sold is prescription-only, i.e. paid for by health insurance companies. Here, the advantage of Zur Rose does not lie in the lower price but in the simplified access. An astonishing number of people don’t take their medication properly or not at all. Zur Rose replaces the cumbersome process of exchanging the paper prescription for the medication at the pharmacy with its healthcare ecosystem in the app. Here, the prescription is available digitally and the medicine can be ordered with one click. In the app, patients check whether the medicine can be combined with others and are reminded to take it in time.
At a first glance, these steps may not seem to make much of a difference. However, they can have a major positive effect: 10% of all hospitalisations happen because people don’t take their medication correctly or stop taking it too early. The app can help to reduce the number of these hospitalisations.
An important question from our impact community came regarding access for older people: They need medication more often, but are they tech-savvy enough to use the app? CEO Walter Oberhänsli gave a resounding yes. The pandemic has shown that older people are also good at using technology and can therefore benefit from the Zur Rose healthcare ecosystem.
Inyova assessment: Clear contribution to the Sustainable Development Goals (SDG 3 “Health and Wellbeing”) and relevant sub-goals.
Footprint
Inyova doesn’t just care about what a company does but also about how they do it. Our preliminary research showed that Zur Rose hasn’t yet published a concrete sustainability strategy. Walter Oberhänsli was refreshingly honest, admitting “Sustainability has always been important to us, but until now it has been on the agenda only implicitly.” As of this year though, Zur Rose has created a sustainability role. The position reports directly to the CEO and works closely with various board members. In 2022, Zur Rose plans to publish their first-ever sustainability report.
CO2 footprint
To tackle the climate crisis, all companies need to reduce their CO2 footprint quickly and drastically. So far, Zur Rose doesn’t publish emissions data and lacks concrete, quantitative reduction targets. However, efforts are being made primarily in the area of transport and logistics. On the subject of packaging, there are clear measures: Whenever possible, filler material is avoided. In the future, Zur Rose would like to adapt the packaging exactly to the size of the medicine package. This way, unnecessary filler material can be avoided and CO2 can be saved accordingly.
Inyova assessment: A first step
With transport and logistics, Zur Rose has already focused on the most relevant area in terms of CO2 footprint. The decisive next steps would be to record all relevant emissions and set concrete reduction targets.
Gender equality
The issue of diversity in leadership positions is very close to the heart of the Inyova impact community. At Zur Rose, Betül Susamis Unaran is the only woman among eight men in top management. Our impact investors took notice and asked what the company was doing about gender equality. According to Walter Oberhänsli, they are “making an effort” by implementing measures such as flexible working hours and promoting female talents.
Inyova assessment: More needs to happen here
Especially considering that the majority of all employees at Zur Rose are women, Zur Rose should ensure more permeability upwards.
Fair wages
When it comes to fair wages, it’s about making sure that the difference between the salary of the top management and the average salary isn’t too big. The bigger the gap, the less fair. On average, board members earn 183 times as much as “normal” employees. At Zur Rose the ratio is 12:1!
Inyova rating: More than fair
In the area of fair wages, Zur Rose is an absolute front-runner.
The most important takeaways
When you do impact investing with Inyova, you invest your money in companies that match your values. You can achieve a concrete impact by using your voice as an investor to influence the company in the direction of sustainable development.
With its handprint, the Zur Rose Group makes an important contribution to better health and well-being by simplifying access to medicine. However, there is still some catching up to do when it comes to the footprint. It’s therefore promising to see that CEO Walter Oberhänsli recognises this and has taken the first steps towards improvement.
The Inyova impact community is eagerly awaiting the first sustainability report, which is due to be published in 2022. We gladly accept the CEO’s offer to hear our suggestions: We want to see concrete data in the sustainability report. Only if there is enough data can we, but also the company itself, measure and track sustainability performance. We’ll be staying tuned for you!
Advertising notice: The information and evaluations presented here are an advertising announcement which has not been prepared in accordance with legal provisions promoting the independence of financial analyses and is not subject to any prohibition of trading following the dissemination of financial analyses. The acquisition of this investment involves considerable risks and may lead to the complete loss of the invested assets. Inyova receives an all-inclusive fee of 0.9 - 1.2 & p.a. for its services, depending on the amount of assets under management. The exact calculation can be found at www.inyova.de/en/fees.
Risk notice: All information is only intended to support your independent investment decision and does not represent a recommendation by Inyova. The product information and calculation examples presented do not claim to be complete or correct. Only the specifications in the asset management contract incl. the further legal documents, which are made available to customers of Inyova via the complete customer documentation, are authoritative. Please read the asset management contract and the other client documents carefully before making an investment decision. The following applies to all shares and ETFs: Past performance is no guarantee of future performance. Information on past performance does not permit forecasts for the future. Investments in securities include the risk of a loss in value. Other securities services may achieve different results. The results for individually managed portfolios as well as the different time full stops may differ due to market conditions, different entry times, different portfolio sizes, individual restrictions and the respective composition of the portfolio.
Disclaimer: Past performance of financial markets and instruments is never an indicator of future performance. The statements or information contained in this document do not constitute a recommendation, offer, or solicitation to buy or sell any security or financial instrument. Inyova GmbH assumes no liability whatsoever with regard to the reliability and completeness of the information contained in this article. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. Furthermore, the statements contained in this document reflect an assessment at the time of publication and are subject to change. References and links to third party websites are outside the responsibility of Inyova GmbH. Any responsibility for such websites is declined.
EU Sustainable Finance Regulation: the terms and categories from this post do not correspond to the terms and categories of the EU Sustainable Finance Regulation. You can find the disclosures and explanations required under the EU Sustainable Finance Regulation at https://inyova.de/en/sustainable-finance-disclosure-regulation..
